Modern Approaches to Pharma QC at CPhI Worldwide 2018

News
Article

This pharma insight briefing from Agilent Technologies will cover the application of Raman and infrared spectroscopy for pharmaceutical quality control (QC).

Dr. Lester Taylor, pharma marketing manager at Agilent Technologies, will host a pharma insight briefing on Oct. 10, 2018 at CPhI Worldwide describing the application of Raman and infrared spectroscopy (IR) for pharmaceutical quality control (QC).

The presentation will include use of Raman for raw materials verification of incoming goods through unopened non-transparent containers and the use of transmission Raman as an alternative to ultra-high-performance liquid chromatography for content uniformity studies. Additionally, use of a next-generation IR instrument using a quantum cascade laser will be described for chemical-imaging studies, including analysis of tablet component distribution, polymorph distribution, salt exchange, and stability studies.

Since obtaining his PhD in the ion optics of mass spectrometers at the University of Manchester Institute of Science and Technology in England, Taylor has worked in the field of mass spectrometry both in the areas of instrumentation and applications development. More recently, he joined Thermo Fisher as the marketing director for life sciences mass spectrometry.  Then in 2009, he joined Agilent as the director of liquid chromatography-mass spectrometry product marketing until May 2014, when he took on the role of pharma market manager. 

The seminar will take place between 1:10pm–1:40pm at the InnoPack & P-MEC Theatre, Hall 4, stand 4F121, at CPhI Worldwide 2018. CPhI will run from Oct 9–11 in Madrid, Spain.

Source: CPhI

Recent Videos
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes